News & Events
SoluBest has recently completed a clinical bio-availability trial on its Nano-Resveratrol formulation . Carried out in recent months, the trial involved 12 healthy volunteers on which SoluBest's latest formulation for Resveratrol (shown in our technology section as SoluDrug 2) was tested. The trial took place at the Soroka medical center under the supervision of Prof. Avraham Danon. Final results indicate SoluBest's formulation exhibited excellent bio-availability of this compound. Last changed: 21/07/2009 at 15:24 Back |